Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| EB Epicrispr BiotechnologiesCompany profile Develops programmable epigenetic medicines to treat genetic diseases like FSHD Develops programmable epigenetic medicines to treat genetic diseases like FSHD | $90M | Series CSeries C+ | Biotech | United States | Investors |
Ranked by rounds participated in · From Jan 1, 2026
Metriport, Arintra, Multiplier
Transfyr, General Intuition, Castelion
Rillet, Castelion, Hadrian
SiFly Aviation, Apollo Atomics, Hopscotch Primary Care
Higgsfield, Lovable, Cambridge Aerospace
Explore published rounds while the next edition is being prepared.
| IT InStore TechnologyCompany profile Provides managed retail technology infrastructure for independent grocers Provides managed retail technology infrastructure for independent grocers | Undisclosed | StrategicUndisclosed | Ecommerce | United States | Investors |
| AB Aureka BiotechnologiesCompany profile Builds biological foundation models and closed-loop infrastructure for drug discovery Builds biological foundation models and closed-loop infrastructure for drug discovery | $100M | Series B | Biotech | United States | Investors |
| CA Builds counter-drone and missile interceptor defense systems | $300M | Series CSeries C+ | Defense tech | United Kingdom | Investors |
| N Generates simulation-ready 3D data for physical AI training | ₩15B | Series B | Robotics | South Korea | Investors |
| V AI platform transforming architectural models into high-quality renders | $2.5M | Undisclosed | Proptech | Norway | Investors |
| W Makes a fabric spray that refreshes and de-wrinkles clothing between washes | $1.2M | Pre-SeedPre-seed | Consumer | United States | Investors |
| V AI-native product decision platform for apparel and consumer goods brands | $22.5M | Growth | Ecommerce | United States | Investors |
| RB Remedium BioCompany profile Develops durable protein therapeutics via gene therapy for chronic diseases Develops durable protein therapeutics via gene therapy for chronic diseases | $10M | Series A | Biotech | United States | Investors |
| DM Discovered MaterialsCompany profile Builds AI agents that discover and accelerate new materials for semiconductor chips Builds AI agents that discover and accelerate new materials for semiconductor chips | $9M | Seed | AI | United States | Investors |